Clinical Trial: Study Protocol of Efficacy and Safety of HAIC with Raltitrexed Combined with Oxaliplatin as Adjuvant Therapy after Hepatectomy in HCC Patients with High Recurrence Risk (China)

Posted On: 2026-09-22

China, Sept. 22 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study Protocol of Efficacy and Safety of HAIC with Raltitrexed Combined with Oxaliplatin as Adjuvant Therapy after Hepatectomy in HCC Patients with High Recurrence Risk'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133041

Registration Time: 2026/09/21

Type: Interventional study

Primary Sponsor: West China Hospital of Sichuan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=343365

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Study Protocol of Efficacy and Safety of HAIC with Raltitrexed Combined with Oxaliplatin as Adjuvant Therapy after Hepatectomy in HCC Patients with High Recurrence Risk (China)